Hanlon Investment Management’s VIVEVE MED INC VIVE Stock Holding History

Hanlon Investment Management’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11	Closed	-$4K	–	135
2019 Q2	$4K	Hold	11	–	–	﹤0.01%	132
2019 Q1	$10K	Buy	+11	New	+$11.7K	﹤0.01%	125

Other funds holding VIVE

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hanlon Investment Management's VIVE Position: Q3 2019 in Review

Hanlon Investment Management sold out of VIVEVE MED INC (VIVE) in Q3 2019, closing a stake of 11 shares — an estimated $4K sold.

Hanlon Investment Management first reported a position in VIVE in Q1 2019 and held it in 2 quarters. The position peaked at $10K in Q1 2019. 11 funds tracked by Wall St. Rank hold VIVE as of Q3 2019.

Hanlon Investment Management reported no remaining VIVEVE MED INC position as of Q3 2019 after selling out during the quarter.
Hanlon Investment Management sold 11 VIVEVE MED INC shares in Q3 2019, an estimated $4K.
Hanlon Investment Management first reported a position in VIVEVE MED INC in Q1 2019 and held it in 2 quarters.
Hanlon Investment Management's VIVEVE MED INC position peaked at $10K in Q1 2019.
11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2019.

Based on Hanlon Investment Management's 13F filing for Q3 2019, filed 7 Nov 2019.